These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 10726227)
1. Mechanisms of action of low doses of polyethylene glycol in the treatment of functional constipation. Chaussade S Ital J Gastroenterol Hepatol; 1999 Nov; 31 Suppl 3():S242-4. PubMed ID: 10726227 [TBL] [Abstract][Full Text] [Related]
2. Use of low dose polyethylene glycol solutions in the treatment of functional constipation. Badiali D; Corazziari E Ital J Gastroenterol Hepatol; 1999 Nov; 31 Suppl 3():S245-8. PubMed ID: 10726228 [TBL] [Abstract][Full Text] [Related]
3. Use of polyethylene glycol solution in slow transit constipation. Bassotti G; Fiorella S; Roselli P; Modesto R Ital J Gastroenterol Hepatol; 1999 Nov; 31 Suppl 3():S255-6. PubMed ID: 10726231 [TBL] [Abstract][Full Text] [Related]
4. Use of polyethylene glycol solution in functional and organic constipation in children. Staiano A Ital J Gastroenterol Hepatol; 1999 Nov; 31 Suppl 3():S260-3. PubMed ID: 10726233 [TBL] [Abstract][Full Text] [Related]
5. Polyethylene glycol 4000 for slow transit constipation. Klauser AG; Mühldorfer BE; Voderholzer WA; Wenzel G; Müller-Lissner SA Z Gastroenterol; 1995 Jan; 33(1):5-8. PubMed ID: 7886986 [TBL] [Abstract][Full Text] [Related]
6. Polyethylene glycol 4000 vs. lactulose for the treatment of neurogenic constipation in myelomeningocele children: a randomized-controlled clinical trial. Rendeli C; Ausili E; Tabacco F; Focarelli B; Pantanella A; Di Rocco C; Genovese O; Fundarò C Aliment Pharmacol Ther; 2006 Apr; 23(8):1259-65. PubMed ID: 16611288 [TBL] [Abstract][Full Text] [Related]
7. Need of the ideal drug for the treatment of chronic constipation. Corazziari E Ital J Gastroenterol Hepatol; 1999 Nov; 31 Suppl 3():S232-3. PubMed ID: 10726224 [TBL] [Abstract][Full Text] [Related]
8. New polyethylene glycol electrolyte solution for the treatment of constipation and faecal impaction. Ferguson A; Culbert P; Gillett H; Barras N Ital J Gastroenterol Hepatol; 1999 Nov; 31 Suppl 3():S249-52. PubMed ID: 10726229 [TBL] [Abstract][Full Text] [Related]
9. Polyethylene glycol solution in subgroups of chronic constipation patients: experience in obstructed defaecation. Bazzocchi G Ital J Gastroenterol Hepatol; 1999 Nov; 31 Suppl 3():S257-9. PubMed ID: 10726232 [TBL] [Abstract][Full Text] [Related]
10. Effects of lactulose and polyethylene glycol on colonic transit. Fritz E; Hammer HF; Lipp RW; Högenauer C; Stauber R; Hammer J Aliment Pharmacol Ther; 2005 Feb; 21(3):259-68. PubMed ID: 15691300 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and optimal dose of daily polyethylene glycol 3350 for treatment of constipation and encopresis in children. Pashankar DS; Bishop WP J Pediatr; 2001 Sep; 139(3):428-32. PubMed ID: 11562624 [TBL] [Abstract][Full Text] [Related]
12. A randomized, placebo-controlled, multicenter study of the safety and efficacy of a new polyethylene glycol laxative. DiPalma JA; DeRidder PH; Orlando RC; Kolts BE; Cleveland MB Am J Gastroenterol; 2000 Feb; 95(2):446-50. PubMed ID: 10685748 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of polyethylene glycol plus electrolytes in the treatment of severe constipation and faecal impaction in adults. Chen CC; Su MY; Tung SY; Chang FY; Wong JM; Geraint M Curr Med Res Opin; 2005 Oct; 21(10):1595-602. PubMed ID: 16238899 [TBL] [Abstract][Full Text] [Related]
14. Clinical subgroups of chronic constipation: exploring the potential of polyethylene glycol. Camilleri M Ital J Gastroenterol Hepatol; 1999 Nov; 31 Suppl 3():S253-4. PubMed ID: 10726230 [TBL] [Abstract][Full Text] [Related]
15. A randomized, prospective, comparison study of polyethylene glycol 3350 without electrolytes and milk of magnesia for children with constipation and fecal incontinence. Loening-Baucke V; Pashankar DS Pediatrics; 2006 Aug; 118(2):528-35. PubMed ID: 16882804 [TBL] [Abstract][Full Text] [Related]
16. Small doses of the unabsorbable substance polyethylene glycol 3350 accelerate oro-caecal transit, but slow gastric emptying in healthy subjects. Coremans G; Vos R; Margaritis V; Ghoos Y; Janssens J Dig Liver Dis; 2005 Feb; 37(2):97-101. PubMed ID: 15733521 [TBL] [Abstract][Full Text] [Related]
17. An open-label study of chronic polyethylene glycol laxative use in chronic constipation. Di Palma JA; Cleveland MV; McGowan J; Herrera JL Aliment Pharmacol Ther; 2007 Mar; 25(6):703-8. PubMed ID: 17311603 [TBL] [Abstract][Full Text] [Related]
18. Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome. Andresen V; Camilleri M; Busciglio IA; Grudell A; Burton D; McKinzie S; Foxx-Orenstein A; Kurtz CB; Sharma V; Johnston JM; Currie MG; Zinsmeister AR Gastroenterology; 2007 Sep; 133(3):761-8. PubMed ID: 17854590 [TBL] [Abstract][Full Text] [Related]
19. Prospective, randomized, parallel-group trial to evaluate the effects of lactulose and polyethylene glycol-4000 on colonic flora in chronic idiopathic constipation. Bouhnik Y; Neut C; Raskine L; Michel C; Riottot M; Andrieux C; Guillemot F; Dyard F; Flourié B Aliment Pharmacol Ther; 2004 Apr; 19(8):889-99. PubMed ID: 15080850 [TBL] [Abstract][Full Text] [Related]
20. A dose determination study of polyethylene glycol 4000 in constipated children: factors influencing the maintenance dose. Dupont C; Leluyer B; Amar F; Kalach N; Benhamou PH; Mouterde O; Vannerom PY J Pediatr Gastroenterol Nutr; 2006 Feb; 42(2):178-85. PubMed ID: 16456412 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]